Skip to main content
Top
Published in: Calcified Tissue International 2/2004

01-04-2004 | Laboratory Investigations

Gene Expression for Extracellular Matrix Proteins in Shockwave-Induced Osteogenesis in Rats

Authors: Kenji Takahashi, Masashi Yamazaki, Takashi Saisu, Arata Nakajima, Sumito Shimizu, Shigeru Mitsuhashi, Hideshige Moriya

Published in: Calcified Tissue International | Issue 2/2004

Login to get access

Abstract

To clarify the mechanisms underlying shockwave-induced osteogenesis, we applied shockwave to rat femoral shafts from the ventral side. We assessed bone mineral content (BMC) and bone mineral density (BMD), and analyzed the spatial and temporal gene expression for pro-α1 (I) collagen (COL1A1), pro-α1 (II) collagen (COL2A1), pro-α1 (X) collagen (COL10A1), osteocalcin (OC) and osteopontin (OPN) using in situ hybridization. On the 21st day post-exposure, BMC and BMD in the exposed femur were elevated by 8.46% and 5.80%, respectively, relative to the unexposed femur. Immediately following exposure, there was evidence of scraping of the cortex and periosteal separation with hemorrhage. On day 4, new periosteal bone formation could be seen on the ventral and dorsal side of the femur. In the newly formed bone, COL1A1, OC and OPN were expressed in osteoblastic cells underlying the periosteum. On day 7, there was progression of periosteal bone and trabeculae formation. COL1A1 and OC were expressed in mature osteoblasts lining the trabeculae, whereas OPN was expressed in immature osteoblastic cells, osteocytes and osteoclasts. On day 14, bone remodeling commenced in the periosteal bone. COL1A1, OC and OPN were still expressed at this stage, however, signals were much weaker. Between 4–7 days, chondrocyte clusters were distributed multi-focally near the exposed site, and there was expression of COL2A1 but not of COL10A1. The results demonstrate that gene expression patterns of shockwave-induced osteogenesis are similar to those of periosteal hard callus formation during fracture healing. Shockwaves can yield dramatic activation of cells in normal long bones, and drive the cells to express genes for osteogenesis.
Literature
1.
go back to reference Chaussy, C, Schmiedt, E, Jocham, D, Brendel, W, Forssmann, ., Walther, V 1982First clinical experiences with extracorporeally induced destruction of kidney stones by shock waves.J Urol127417420PubMed Chaussy, C, Schmiedt, E, Jocham, D, Brendel, W, Forssmann, ., Walther, V 1982First clinical experiences with extracorporeally induced destruction of kidney stones by shock waves.J Urol127417420PubMed
2.
go back to reference Valchanou, VD, Michailov, P 1991High energy shock waves in the treatment of delayed and nonunion of fractures.Int Orthop15181184PubMed Valchanou, VD, Michailov, P 1991High energy shock waves in the treatment of delayed and nonunion of fractures.Int Orthop15181184PubMed
3.
go back to reference Haupt, G 1997Use of extracorporeal shock waves in the treatment of pseudoarthrosis, tendinopathy and other orthopedic diseases.J Urol158411PubMed Haupt, G 1997Use of extracorporeal shock waves in the treatment of pseudoarthrosis, tendinopathy and other orthopedic diseases.J Urol158411PubMed
4.
go back to reference Schleberger, R, Senge, T 1992Non-invasive treatment of long-bone pseudarthrosis by shock waves (ESWL).Arch Orthop Trauma Surg111224227PubMed Schleberger, R, Senge, T 1992Non-invasive treatment of long-bone pseudarthrosis by shock waves (ESWL).Arch Orthop Trauma Surg111224227PubMed
5.
go back to reference Vogel, J, Hopf, C, Eysel, P, Rompe, JD 1997Application of extracorporeal shock-waves in the treatment of pseudarthrosis of the lower extremity: preliminary results.Arch Orthop Trauma Surg116480483PubMed Vogel, J, Hopf, C, Eysel, P, Rompe, JD 1997Application of extracorporeal shock-waves in the treatment of pseudarthrosis of the lower extremity: preliminary results.Arch Orthop Trauma Surg116480483PubMed
6.
go back to reference Kaulesar-Sukul, DM, Johanenes, E, Pierik, EG, van Eijck, GJ, Kristelijn, MJ 1993The effect of high energy shock waves focused on cortical bone: an in vitro study.J Surg Res544651CrossRefPubMed Kaulesar-Sukul, DM, Johanenes, E, Pierik, EG, van Eijck, GJ, Kristelijn, MJ 1993The effect of high energy shock waves focused on cortical bone: an in vitro study.J Surg Res544651CrossRefPubMed
7.
go back to reference Delius, M, Draenert, K, Al Diek, Y, Draenert, Y 1995Biological effect of shock waves: in vivo effect of high energy pulses on rabbit bone.Ultrasound Med Biol2112191225PubMed Delius, M, Draenert, K, Al Diek, Y, Draenert, Y 1995Biological effect of shock waves: in vivo effect of high energy pulses on rabbit bone.Ultrasound Med Biol2112191225PubMed
8.
go back to reference Saisu, T, Goto, S, Wada, Y, Takahashi, K, Mitsuhashi, S, Harada, Y, Minami, S, Moriya, H, Kamegaya, M 1999Irradiation of the extracorporeal shock wave to the immature long bone caused overgrowth and local increase in bone mineral content.Trans Orthop Res Soc2434 Saisu, T, Goto, S, Wada, Y, Takahashi, K, Mitsuhashi, S, Harada, Y, Minami, S, Moriya, H, Kamegaya, M 1999Irradiation of the extracorporeal shock wave to the immature long bone caused overgrowth and local increase in bone mineral content.Trans Orthop Res Soc2434
9.
go back to reference Saisu, T, Takahashi, K, Mitsuhashi, S, Wada, Y, Moriya, H, Kamegaya, M 2000Acetabular augmentation induced by extracorporeal shock waves in rabbits.Trans Orthop Res Soc25519 Saisu, T, Takahashi, K, Mitsuhashi, S, Wada, Y, Moriya, H, Kamegaya, M 2000Acetabular augmentation induced by extracorporeal shock waves in rabbits.Trans Orthop Res Soc25519
10.
go back to reference Yamazaki, M, Majeska, RJ, Yoshioka, H, Moriya, H, Einhorn, TA 1997Spatial and temporal expression of fibril-forming minor collagen genes (type V and type XI) during fracture healing.J Orthop Res15757764PubMed Yamazaki, M, Majeska, RJ, Yoshioka, H, Moriya, H, Einhorn, TA 1997Spatial and temporal expression of fibril-forming minor collagen genes (type V and type XI) during fracture healing.J Orthop Res15757764PubMed
11.
go back to reference Nakajima, F, Ogasawara, A, Goto, K, Moriya, H, Ninomiya, Y, Einhorn, TA, Yamazaki, M 2001Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor.J Orthop Res19935944PubMed Nakajima, F, Ogasawara, A, Goto, K, Moriya, H, Ninomiya, Y, Einhorn, TA, Yamazaki, M 2001Spatial and temporal gene expression in chondrogenesis during fracture healing and the effects of basic fibroblast growth factor.J Orthop Res19935944PubMed
12.
go back to reference Yamazaki, M, Nakajima, F, Ogasawara, A, Moriya, H, Majeska, RJ, Einhorn, TA 1999Spatial and temporal distribution of CD44 and osteopontin in fracture callus.J Bone Joint Surg Br81508515 Yamazaki, M, Nakajima, F, Ogasawara, A, Moriya, H, Majeska, RJ, Einhorn, TA 1999Spatial and temporal distribution of CD44 and osteopontin in fracture callus.J Bone Joint Surg Br81508515
13.
go back to reference Nakajima, A, Nakajima, F, Shimizu, S, Ogasawara, A, Wanaka, A, Moriya, H, Einhorn, TA, Yamazaki, M 2001Spatial and temporal gene expression for fibroblast growth factor type I receptor (FGFR1) during fracture healing in the rat.Bone29458466CrossRefPubMed Nakajima, A, Nakajima, F, Shimizu, S, Ogasawara, A, Wanaka, A, Moriya, H, Einhorn, TA, Yamazaki, M 2001Spatial and temporal gene expression for fibroblast growth factor type I receptor (FGFR1) during fracture healing in the rat.Bone29458466CrossRefPubMed
14.
go back to reference Nakase, T, Takaoka, K, Hirakawa, K, Hirota, S, Takemura, T, Onoue, H, Takebayashi, K, Kitamura, Y, Nomura, S 1994Alternations in the expression of osteonectin, osteopontin and osteocalcin mRNAs during the development of skeletal tissues in vivo.Bone Miner26109122 Nakase, T, Takaoka, K, Hirakawa, K, Hirota, S, Takemura, T, Onoue, H, Takebayashi, K, Kitamura, Y, Nomura, S 1994Alternations in the expression of osteonectin, osteopontin and osteocalcin mRNAs during the development of skeletal tissues in vivo.Bone Miner26109122
15.
go back to reference Somerman, MJ, Prince, CW, Sauk, JJ, Foster, RA, Butler, WT 1987Mechanisms of fibroblast attachment to bone extracellular matrix: role of a 44 kirodalton bone phosphoprotein.J Bone Miner Res2259265 Somerman, MJ, Prince, CW, Sauk, JJ, Foster, RA, Butler, WT 1987Mechanisms of fibroblast attachment to bone extracellular matrix: role of a 44 kirodalton bone phosphoprotein.J Bone Miner Res2259265
16.
go back to reference Kusnierczak, D, Brocai, DR, Vettel, U, Loew, M 2000The influence of extracorporeal shock-wave application (ESWA) on the biological behavior of bone cells in vitro.Z Orthop Ihre Grenzgeb1382933CrossRefPubMed Kusnierczak, D, Brocai, DR, Vettel, U, Loew, M 2000The influence of extracorporeal shock-wave application (ESWA) on the biological behavior of bone cells in vitro.Z Orthop Ihre Grenzgeb1382933CrossRefPubMed
17.
go back to reference Einhorn, TA 1998The cell and molecular biology of fracture healing.Clin Orthop355S7S21PubMed Einhorn, TA 1998The cell and molecular biology of fracture healing.Clin Orthop355S7S21PubMed
Metadata
Title
Gene Expression for Extracellular Matrix Proteins in Shockwave-Induced Osteogenesis in Rats
Authors
Kenji Takahashi
Masashi Yamazaki
Takashi Saisu
Arata Nakajima
Sumito Shimizu
Shigeru Mitsuhashi
Hideshige Moriya
Publication date
01-04-2004
Publisher
Springer-Verlag
Published in
Calcified Tissue International / Issue 2/2004
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-003-0043-3

Other articles of this Issue 2/2004

Calcified Tissue International 2/2004 Go to the issue

Laboratory Investigations

Erratum

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine